Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment

NCT07651878 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

CML (Chronic Myelogenous Leukemia)

Interventions

BIOLOGICAL: vididencel

Sponsor

Mendus

Collaborators

[object Object]
[object Object]